MedAd­vi­sor phar­ma­cies up

Pharmacy Daily - - Front Page -

LISTED dig­i­tal med­i­ca­tions man­age­ment com­pany MedAd­vi­sor now has 55% of Aus­tralian phar­ma­cies on board, with num­bers at 3,100 af­ter a strong Sep quar­ter ex­pan­sion spurt.

Con­nected users now ex­ceed 1.1 mil­lion, the com­pany said.

Cash re­ceipts for the pe­riod amounted to $1.86m, up 36% as against Q1 FY 18 at $1.36m.

CEO Robert Read said “we con­tinue to grow our do­mes­tic busi­ness while scal­ing up to take ad­van­tage of sig­nif­i­cant growth op­por­tu­ni­ties in both do­mes­tic and in­ter­na­tional mar­kets”.

Read high­lighted the growth in sites us­ing PlusOne and said “the in­creased engagement will en­sure growth of pro­grams that can be de­liv­ered to the 7 mil­lion-plus pa­tients at these phar­ma­cies, fur­ther driv­ing user-based rev­enue from trans­ac­tional fees”.

He also com­mented that while the op­por­tu­nity in the hospi­tal mar­ket is sig­nif­i­cant, the com­pany is now fo­cused on de­vel­op­ing the of­fer­ing and si­mul­ta­ne­ously im­prov­ing its ser­vices to GPs.

In ad­di­tion Read said the com­pany would in­crease both the global con­nec­tiv­ity of the plat­form and its busi­ness de­vel­op­ment ac­tiv­i­ties in its core in­ter­na­tional mar­kets, espe­cially in the US where founder and Prod­uct Man­ager In­ter­na­tional, Josh Swin­ner­ton, has re­lo­cated.

“These mar­kets have the po­ten­tial to rapidly change the scope and scale of MedAd­vi­sor,” Read noted.

“We are op­ti­mistic about in­ter­na­tional op­por­tu­ni­ties in the mar­kets that we are fo­cus­ing on and are well ad­vanced in the US,” he said, with the in­te­gra­tion of MedAd­vi­sor into the plat­form of US dis­pens­ing soft­ware provider PDX “pro­gress­ing on track.”

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.